Abstract
Antiphospholipid syndrome is a disease that was discovered just 25 years ago. Although clinical manifestations have been clearly described, pathogenetic mechanisms are still barely understood. A recent hypothesis involves inflammation in the setting of antiphospholipid syndrome morbidity and experimental data support the activation of a complement cascade as a pivotal event in its physiopathology. In this review, the authors will analyze the recent literature, focusing on contemporary and emerging aspects of complement-mediated disease pathogenesis, and pinpoint the clinical significance of this novel finding. © 2013 Future Medicine Ltd.
Lingua originale | English |
---|---|
pagine (da-a) | 399-405 |
Numero di pagine | 7 |
Rivista | International Journal of Clinical Rheumatology |
Volume | 8 |
DOI | |
Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- adverse pregnancy outcome
- antiphospholipid syndrome
- complement pathway
- hypocomplementemia